A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2001
11/15/2001	WO2001000880A3 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
11/15/2001	WO2000061780A9 Compositions and methods for extending life span
11/15/2001	WO2000055323A9 Differential expression of organellar gene products
11/15/2001	WO2000050584A3 Methods and compositions for enhancing in vivo gene delivery/expression
11/15/2001	WO2000020619A8 Secreted renilla luciferase
11/15/2001	WO2000015819A9 Packaging cell lines for hiv-derived retroviral vector particles
11/15/2001	US20010041681 Therapeutically useful synthetic oligonucleotides
11/15/2001	US20010041679 Multiple site delivery of adenoviral vector for the induction of angiogenesis
11/15/2001	US20010041668 Selecting compound that is functionally equivalent to a gene product expressed in an embryo's extraembryonic tissue, causing the compound to access the cells to stimulate cells to undergo hematopoiesis and vascular growth
11/15/2001	US20010041350 Human DNA ligase III
11/15/2001	US20010041178 Preventing airway mucus production by administration of EGF-R antagonists
11/15/2001	US20010041173 Helper-dependent cloning vectors where most viral genes have been removed and have increased safety and capacity for larger insertions
11/15/2001	CA2776904A1 A device for forming or increasing the number of undifferentiated cells
11/15/2001	CA2409679A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy
11/15/2001	CA2409510A1 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001	CA2408732A1 Modified es cells and es cell-specific gene
11/15/2001	CA2408632A1 Ph domain-interacting protein
11/15/2001	CA2408576A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/15/2001	CA2408559A1 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof
11/15/2001	CA2408349A1 Method of regulating angiogenesis unsing ryk protein
11/15/2001	CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	CA2408255A1 Methods for stimulating nervous system regeneration and repair by regulating arginase 1 and polyamine synthesis
11/15/2001	CA2408253A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/15/2001	CA2408213A1 Protein complexes and assays for screening anti-cancer agents
11/15/2001	CA2408051A1 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
11/15/2001	CA2408002A1 Enzymatic assays for screening anti-cancer agents
11/15/2001	CA2407698A1 Repair of nerve damage
11/15/2001	CA2379095A1 Antisense gene-trap vector
11/14/2001	EP1154019A2 G-protein coupled receptor (HFGAN72X)
11/14/2001	EP1153136A2 Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors
11/14/2001	EP1153131A2 Peroral gene therapy of diabetes and obesity
11/14/2001	EP1153129A1 Method of treating restenosis by antisense targeting of c-myc
11/14/2001	EP1153128A1 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
11/14/2001	EP1153038A1 Therapeutics and diagnostics based on a il-1b mutation
11/14/2001	EP1153036A1 Alpha-2-macroglobulin therapies and drug screening methods for alzheimer's disease
11/14/2001	EP1152771A2 Adjuvant and cell maturation agent
11/14/2001	EP1117720A4 Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier
11/14/2001	EP0652948B1 Development of a vector to target gene expression to the epidermis of transgenic animals
11/14/2001	CN1322250A Peptides derived from attachment (G) protein of respiratory syncytial virus
11/14/2001	CN1322246A Restin and methods of use thereof
11/14/2001	CN1322244A Tumor necrosis factor-gamma
11/14/2001	CN1322243A Urate oxidase
11/14/2001	CN1322213A Treatment of inflammatory disease
11/14/2001	CN1322143A Gene therapy for cerebrovasclar disorders
11/14/2001	CN1322142A Method for producing and delivery of protein in vivo
11/14/2001	CN1321745A Macrophage inflammatory protein -3, -4 and -1 gamma
11/14/2001	CN1321654A Novel polypeptide-human pax protein 11.4 and polynucleotide for coding this polypeptide
11/13/2001	US6316692 Insertion of nucleotide sequences into genomes; inject sample into testes, recover preferential polypeptide from transformed cells
11/13/2001	US6316601 Antibodies specific for β6 integrins
11/13/2001	US6316597 Protein for use in treatment of bone or cartilage defects
11/13/2001	US6316421 Pentaerythritol lipid derivatives and nuleic-acid complexes
11/13/2001	US6316420 Immunization against multiple sclerosis with administering to subject a naked dna nucleic acid construct encoding a cytokine
11/13/2001	US6316418 Regulated apoptosis
11/13/2001	US6316408 Methods of use for osetoprotegerin binding protein receptors
11/13/2001	US6316261 Method for concerted integration of donor DNA molecules using retroviral integrase proteins
11/13/2001	US6316260 Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraether lipid derivatives, and use thereof
11/13/2001	US6316255 Transduced cultured liver cells; for use in the treatment and prevention of liver disorders
11/13/2001	US6316253 Plasmid for use as a tool in genetic engineering and gene transfer
11/13/2001	US6316239 HKABY60 kinase family polypeptides
11/13/2001	US6316219 Compounds
11/13/2001	US6316213 Methods for the early diagnosis of ovarian, breast and lung cancer
11/13/2001	US6316208 Methods for determining isolated p27 protein levels and uses thereof
11/13/2001	US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/13/2001	US6316199 Arginase II
11/13/2001	US6315992 Generating cartilage in a mammal using fibroblasts transfected with a vector encoding TGF-β-1
11/13/2001	US6315978 Bioconjugates and delivery of bioactive agents
11/13/2001	CA1341319C Modified hepatocytes and uses therefor
11/09/2001	CA2305787A1 Cxcr4 antagonist treatment of hematopoietic cells
11/08/2001	WO2001084565A2 Method and apparatus for manufacture of magnetizable microparticles
11/08/2001	WO2001084158A1 Use of the g protein coupled receptor gpr3 to identify appetite control agents
11/08/2001	WO2001083796A2 Adenoviral vectors for tumor specific gene expression and uses thereof
11/08/2001	WO2001083783A2 In vivo loading of mhc
11/08/2001	WO2001083772A1 Splice variant of camp phosphodiesterase type 7 (pde7a3)
11/08/2001	WO2001083750A2 Dendritic cell co-stimulator molecules
11/08/2001	WO2001083749A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	WO2001083748A1 Novel g protein-coupled receptor protein and dna thereof
11/08/2001	WO2001083740A2 Splice-region antisense composition and method
11/08/2001	WO2001083735A1 Methods and compositions for effecting homologous recombination
11/08/2001	WO2001083730A2 Recombinant lentiviral vectors pseudotyped in envelopes containing filovirus binding domains
11/08/2001	WO2001083729A2 Vectors for ocular transduction and use thereof for genetic therapy
11/08/2001	WO2001083722A2 Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly
11/08/2001	WO2001083720A2 23686, a novel human aminotransferase and uses therefor
11/08/2001	WO2001083716A2 Immortalized lines of endothelial brain cells and therapeutic application thereof
11/08/2001	WO2001083715A2 Derivation of midbrain dopaminergic neurons from embryonic stem cells
11/08/2001	WO2001083711A2 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus
11/08/2001	WO2001083710A2 Clearance of neoplastic cells from mixed cellular compositions using viruses
11/08/2001	WO2001083705A1 Myocardial cell proliferation-associated genes
11/08/2001	WO2001083698A2 Compositions and methods for inducing activation of dendritic cells
11/08/2001	WO2001083692A2 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
11/08/2001	WO2001083562A2 Hybrid protein and vector encoding the same for inhibition of angiogenesis
11/08/2001	WO2001083558A1 Agonists/antagonists of the gpr56 receptor as appetite control agents
11/08/2001	WO2001083553A2 G protein-coupled receptors
11/08/2001	WO2001083543A1 Human wingless-like gene
11/08/2001	WO2001083533A1 Helicobacter pylori antigens: fusion of hpaa and hpa44
11/08/2001	WO2001083532A1 Helicobacter pylori antigens: fusion of fay 31 and hpa 44
11/08/2001	WO2001083530A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	WO2001083524A2 Rna metabolism proteins
11/08/2001	WO2001083514A2 Nucleic acids encoding a regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001	WO2001083513A2 Antisense modulation of inhibitor of dna binding-1 expression

1 ... 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 ... 870